Discomfort With REMS Highlighted At Negative Hydexor Advisory Committee

 
• By Sarah Karlin-Smith
FDA Advisory Committee Feature image
Charleston was unsuccessful at its second advisory committee for Hydexor

More from US FDA Performance Tracker

More from Regulatory Trackers